Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect.